🇯🇵 Japanese, 25 October 2026, AI funding
Nour Raises Funds with AI-Based Blood and Cell Analysis Equipment
Nour's stock price surged 29.94% to 2170 won after the company announced a third-party allocation of 2.8 billion won.
Nour, a company that manufactures AI-based blood and cell analysis diagnostic equipment, has seen its stock price surge after announcing a third-party allocation of 2.8 billion won. The company will issue 1.1 million new shares at 2,500 won per share. The third-party allocation is aimed at raising funds for operating capital.
The company’s stock price has been on the rise since it announced a third-party allocation decision on the 23rd. It has now reached a record high of 2,170 won, up 500 won from the previous day.
The increase in stock price is attributed to the fact that the largest shareholder will be replaced by Earth Holdings after the completion of the capital increase. This has led to a surge in investor buying.